IOVANCE BIOTHERAPEUTICS, INC. Property, Plant and Equipment, Gross
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Property, Plant and Equipment, Gross of $187.85 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Gross $187.85M.
- 2026-03-31: Property, Plant and Equipment, Gross $183.77M.
- 2025-12-31: Property, Plant and Equipment, Gross $179.88M.
- 2025-09-30: Property, Plant and Equipment, Gross $171.97M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $187.85M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $183.77M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $179.88M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $171.97M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $164.58M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $150.35M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $145.10M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $149.34M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $144.84M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $142.68M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $141.94M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $138.37M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $134.85M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $129.30M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $121.95M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $114.69M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $112.65M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $112.01M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $109.63M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $95.38M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $86.44M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $78.70M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $64.74M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $13.03M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $6.64M 10-K · filed 2020-02-25 | |
| 2017-12-31 | $5.48M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $5.39M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $5.12M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $5.10M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $4.46M 10-K · filed 2018-03-12 | |
| 2015-12-31 | $2.78M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $2.63M 10-Q · filed 2015-11-06 | |
| 2014-12-31 | $1.64M 10-K · filed 2016-03-11 | $1.64M 10-K · filed 2015-03-16 |
| 2013-12-31 | $43.76K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |